Weissman M M, Wolk S, Wickramaratne P, Goldstein R B, Adams P, Greenwald S, Ryan N D, Dahl R E, Steinberg D
Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Arch Gen Psychiatry. 1999 Sep;56(9):794-801. doi: 10.1001/archpsyc.56.9.794.
The continuity in adulthood of major depressive disorder (MDD) first arising before puberty is largely unknown. This information could guide early treatment and clarify the appropriateness of including children with MDD in genetic studies.
Eighty-three subjects with onset of MDD, 44 subjects with anxiety disorder and no MDD, and 91 subjects with no evidence of past or current psychiatric disorders were assessed by two psychiatrists before puberty (Tanner stage < III) and were evaluated 10 to 15 years later as adults by an independent team without knowledge of the initial diagnosis.
The clinical outcome of children with prepubertal-onset MDD in adulthood includes a high risk of suicide attempts (nearly 3-fold compared with normal controls and 2-fold compared with children with anxiety) and bipolar disorder. Compared with controls, both the children with MDD and those with anxiety went on to have increased risk of substance abuse and conduct disorder but not other disorders, increased use of longterm psychiatric and medical services, and overall impaired functioning. Children with prepubertal-onset MDD with a recurrence of MDD during follow-up had higher rates of MDD in their first-degree relatives.
There is high morbidity in clinically referred children with prepubertal-onset MDD and anxiety, but continuity and specificity of MDD or anxiety disorder in adulthood is less clear. Caution is warranted in selecting clinically referred children with prepubertal-onset MDD for inclusion in genetic studies unless they have a family history of MDD and recurrence of MDD over time.
青春期前首次出现的重度抑郁症(MDD)在成年期的延续情况在很大程度上尚不清楚。这一信息可为早期治疗提供指导,并阐明将患有MDD的儿童纳入基因研究的合理性。
83名患有MDD的受试者、44名患有焦虑症但无MDD的受试者以及91名无既往或当前精神疾病证据的受试者在青春期前(坦纳分期<III期)由两名精神科医生进行评估,并在10至15年后由一个独立团队作为成年人进行评估,该团队不知道初始诊断情况。
青春期前发病的MDD儿童成年后的临床结局包括自杀未遂风险高(与正常对照组相比近3倍,与焦虑症儿童相比2倍)以及双相情感障碍。与对照组相比,患有MDD的儿童和患有焦虑症的儿童继续出现药物滥用和品行障碍的风险增加,但其他障碍风险未增加,长期精神科和医疗服务的使用增加,整体功能受损。在随访期间MDD复发的青春期前发病的MDD儿童,其一级亲属中MDD的发生率更高。
临床上转诊的青春期前发病的MDD和焦虑症儿童发病率较高,但MDD或焦虑症在成年期的延续性和特异性尚不清楚。在选择临床上转诊的青春期前发病的MDD儿童纳入基因研究时应谨慎,除非他们有MDD家族史且MDD随时间复发。